Search for: "MYLAN, INC." Results 381 - 400 of 674
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jan 2012, 11:58 pm by Lawrence B. Ebert
Mylan Inc., No. 2:09cv1692, 2009 U.S. [read post]
10 Jan 2012, 12:43 pm by Phil
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
8 Jan 2012, 9:05 pm by Patent Docs
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
6 Jan 2012, 1:25 pm by Bexis
Mylan, Inc., No. 11:1-CV-03037-MHS, slip op. [read post]
18 Dec 2011, 3:45 pm by Patent Docs
• Defendants: Mylan Pharmaceuticals Inc.; Mylan, Inc. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
12 Dec 2011, 1:28 pm
Case New Holland, Inc., 566 F.3d 1372, 1378-79 (Fed. [read post]
13 Nov 2011, 9:40 pm by Patent Docs
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
31 Oct 2011, 6:46 am by Steve McConnell
They are also now big, big litigation.You might think that last week's decision in Hughes v Mylan, Inc., 2011 U.S. [read post]
21 Oct 2011, 7:40 am by Phil
The following is excerpted from an October 20, 2011 Mylan press release available on its website: Dey Pharma L.P., a subsidiary of Mylan Inc. [read post]
20 Oct 2011, 7:53 am by Varun Chhonkar
Famy Care, a Mumbai-based women healthcare speciality company, jointly with global generic company Mylan Inc. has entered into a settlement agreement with Warner Chilcott resolving ongoing paragraph IV lawsuit related to Femcon Fe chewable tablets, an oral low-dose (28-days) contraceptive regimen of 21 active chewable tablets of norethindrone and ethinyl estradiol (EE) combination followed by 7 [read post]
12 Oct 2011, 12:33 pm by Jeffrey May
In addition, the Court denied a petition for certiorari brought by generic drug manufacturer Mylan Laboratories, Inc. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]